Caladrius Biosciences: The Business Model is Intriguing, But the Cash Position Is Weak (CLBS, $0.57, No Opinion at this time)Tuesday, May 24, 2016 · 11:31 am |
|
There are 1 reports on file. |
Caladrius Biosciences: The Business Model is Intriguing, But the Cash Position Is Weak (CLBS, $0.57, No Opinion at this time)Tuesday, May 24, 2016 · 11:31 am |
|
There are 1 reports on file. |